Literature DB >> 938633

Conformation and unfolding thermodynamics of epidermal growth factor and derivatives.

L A Holladay, C R Savage, S Cohen, D Puett.   

Abstract

Mouse submaxillary epidermal growth factor (EGF) is a 53-residue single chain peptide hormone of known amino acid sequence which contains three disulfides, five tyrosines, and two tryptophans. Circular dichroic (CD) spectra have been obtained and resolved for EGF, several well-characterized chemical and enzymic derivatives, and related low molecular weight model compounds. Assignments have been made to most of the resolved bands; these include the peptide, aromatic, and disulfide chromophores. From a comparison of the rotational strength of the 213-nm resolved CD band in native EGF with that of standard proteins, EGF is estimated to contain about 22% beta structure and no alpha helicity. A derivative of EGF lacking the five carboxyl-terminal residues (prepared by limited trypsin digestion) and the cyanogen bromide derivative, in which there is a single main-chain cleavage at residue 21, have spectra properties indicative of approximately 10 and 12% beta structure, respectively. The near-ultraviolet CD spectra of the derivatives are similar to, albeit not identical with, that of EGF. The rotational strengths characteristic of the side-chain chromophores in EGF and these derivatives are several-fold higher than the corresponding values in low molecular weight model compounds. Thus, it appears that EGF and these modified forms contain a stable (and similar) tertiary structure. In contrast, the S-aminoethylated derivative of EGF exhibits a drastically altered CD spectrum relative to EGF indicating a different conformation(s). Equilibrium studies on the guanidinium hydrochloride (GdmCl) mediated reversible unfolding of EGF showed that the transition midpoint is quite high (i.e., 6.89 M GdmCl at 25.0 degrees C), thus, indicating considerable stability. From these data a rough estimate of 16 kcal/mol can be made for the unfolding free energy (delta G degrees) of EGF in the absence of denaturant. Interestingly, EGF exhibits greater stability characteristics than several proteins two to four times its size. The cyanogen bromide derivative of EGF exhibited greatly reduced stability characteristics, e.g., the transition midpoint occurred at 4.19 M GdmCl (25.0 degrees C) and delta G degrees was estimated to be approximately 4 kcal/mol. Thus, a single main-chain cleavage reduced the stability of EGF by about 70%. Thermal transitions of EGF and the cyanogen bromide derivative in the presence of concentrated GdmCl are characterized by a relatively high enthalpy of about 25 kcal/mol at 40 degrees C and a low (probably zero) heat capacity. From these thermodynamic parameters one can calculate that the large reduction in delta G degrees due to scission of the single peptide bond between residues 21 and 22 can be attributed almost completely to a change in entropy; e.g., at 40 degrees C the apparent entropy of unfolding of EGF is 20.4 cal mol-1 deg-1 while that of the cyanogen bromide derivative is 66.4 cal mol-1 deg-1.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 938633     DOI: 10.1021/bi00657a023

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  18 in total

1.  Circular dichroism of human urinary Tamm-Horsfall glycoprotein.

Authors:  D Puett; L A Holladay; J P Robinson
Journal:  Mol Cell Biochem       Date:  1977-04-12       Impact factor: 3.396

2.  Epidermal growth factor: in vivo ocular studies.

Authors:  J H Elliott
Journal:  Trans Am Ophthalmol Soc       Date:  1980

3.  Temperature-induced unfolding of epidermal growth factor (EGF): insight from molecular dynamics simulation.

Authors:  Chunli Yan; Varun Pattani; James W Tunnell; Pengyu Ren
Journal:  J Mol Graph Model       Date:  2010-04-04       Impact factor: 2.518

4.  A synthetic approach to structure-function relationships in the murine epidermal growth factor molecule.

Authors:  W F Heath; R B Merrifield
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

5.  Enzymatic fragmentation of tetanus toxin. Identification and characterization of an atoxic, immunogenic fragment.

Authors:  J P Robinson; H C Chen; J H Hash; D Puett
Journal:  Mol Cell Biochem       Date:  1978-10-13       Impact factor: 3.396

6.  Synthesis and conformational characterization of the epidermal growth factor-like domain of blood coagulation factor IX carrying xylosyl-glucose.

Authors:  Mayuko Kitamura; Hironobu Hojo; Yoshiaki Nakahara; Takeshi Ishimizu; Sumihiro Hase
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

7.  Biologically active synthetic fragments of epidermal growth factor: localization of a major receptor-binding region.

Authors:  A Komoriya; M Hortsch; C Meyers; M Smith; H Kanety; J Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

8.  Visualization by fluorescence of the binding and internalization of epidermal growth factor in human carcinoma cells A-431.

Authors:  H Haigler; J F Ash; S J Singer; S Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

9.  Identification of two anti-parallel beta-sheet conformations in the solution structure of murine epidermal growth factor by proton magnetic resonance.

Authors:  G T Montelione; K Wüthrich; E C Nice; A W Burgess; H A Scheraga
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

10.  Interactions among the epidermal growth factor-like modules of thrombospondin-1.

Authors:  Yuanyuan Liu; Douglas S Annis; Deane F Mosher
Journal:  J Biol Chem       Date:  2009-06-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.